Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; Scientific and technological services featuring pharmacogenomic testing analysis and evaluation of buccal, saliva and other biological samples for the purpose of analyzing how an individual's genetic and non-genetic factors affect their response to drugs, improve drug selection and dosage recommendations, select initial and subsequent medications, identify drug-drug interactions, avoid adverse drug reactions, develop clinical treatment decision support recommendations, and support other medical diagnostic products and prescription drugs; determining a patient's disease and drug response phenotype through evaluation of chromatin state, genomic regulatory elements, epigenomics, proteomics, metabolomics, transcriptomics, environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; scientific and technological services featuring testing, analysis and evaluation of buccal, saliva, blood and other biological samples for the purpose of supporting drug clinical trials, and research into the field of new drug development and drug repurposing